The united states school of aerospace medicine epidemiology laboratory (usafsam/PHE) requires an automated walk away platform for instrumentation, reagents, consumable and support to perform…
Ended Awarded
- Contract number
- FA239625FB066
- Awardee
-
Werfen USA LLC UEI JA87HT8KP2M2
- Awarding agency
-
Air Force
Department of Defense
- Obligated
- $35,339
Award facts
- Contract value 100% obligated
- $35,338.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- WPAFB, OH 45433, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $35,338.50 firm fixed-price blanket purchase agreement call to Werfen USA LLC for an automated walk-away platform to perform autoimmune assays at the United States School of Aerospace Medicine Epidemiology Laboratory located in Wright-Patterson, Ohio. The procurement, which closed on February 24, 2025, with an ultimate completion date of February 25, 2025, does not include a small business set-aside designation. This call order draws from an existing indefinite delivery vehicle contract between Werfen and the Defense Health Agency valued at $1.29 million through May 2030 that covers automated autoimmune testing platforms, instrumentation, reagents, and consumables.
Werfen USA LLC, a Bedford, Massachusetts-based manufacturer specializing in in vitro diagnostic equipment and clinical laboratory instrumentation, is well-positioned to fulfill this requirement given its extensive portfolio of federal contracts across the Department of Veterans Affairs and Defense Health Agency. The company maintains established relationships with federal healthcare systems and has demonstrated expertise in supplying advanced diagnostic testing platforms, reagents, and technical support services. This call order represents continued utilization of Werfen's existing autoimmune testing capabilities within the Defense Health Agency's broader diagnostic testing operations across military medical treatment facilities.
Description
The united states school of aerospace medicine epidemiology laboratory (usafsam/PHE) requires an automated walk away platform for instrumentation, reagents, consumable and support to perform autoimmune assays.
Quick answers
Who was awarded contract FA239625FB066?
FA239625FB066 was awarded to Werfen USA LLC by Air Force (Department of Defense) on February 24, 2025.
How much is contract FA239625FB066 worth?
The government has obligated $35,339 on FA239625FB066.
Which agency awarded contract FA239625FB066?
Air Force (Department of Defense) awarded FA239625FB066, with funding from Defense Health Agency (Department of Defense).
Is contract FA239625FB066 an order under another contract?
Yes. FA239625FB066 is a BPA call under FA860120A0006, a blanket purchase agreement.
Was contract FA239625FB066 competed?
The extent of competition for FA239625FB066 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award